To The Moon

$Inhibrx Biosciences(INBX)$

$Inhibrx Biosciences(INBX) Soared +36.88%: Biotech Rocket Ignites on M&A Buzz, $115 Target in Sight 🚀

Latest Close Data

Closed at $115.09 on 2026-04-23, surging +36.88% with a massive intraday range of $100.00 - $155.29. The close is just $0.20 shy of its 52-week high of $155.29.

Core Market Drivers

The primary catalyst is a Reuters report indicating major pharmaceutical players, including Merck, are showing acquisition interest in the company's experimental cancer drug pipeline.

This M&A speculation ignited a powerful rally.

Technical Analysis

• The surge was accompanied by explosive volume (2.74M shares, ~7.8x avg), confirming strong institutional interest.

• The 6-day RSI rocketed to 88.19, entering extreme overbought territory, signaling a potential near-term pullback.

• However, the MACD (6.62) and signal line (2.89) both accelerated sharply upward, showing strong bullish momentum.

Key Price Levels

• Immediate Pivot: $115.09 (Today's Close). Holding above is key for continuation.

• Primary Support: $83.16 (Previous Resistance). A critical level for any retracement.

• Strong Resistance: $155.29 (52-Week High). The next major target and psychological barrier.

Valuation Perspective

The stock trades at a TTM P/S of ~1,287.6, astronomically high by any standard, reflecting its pre-revenue biotech status where valuation hinges entirely on pipeline potential and M&A prospects.

Analyst Targets

One analyst firm has a price target of $300. Consensus sentiment among the two tracked analysts is mixed (1 Strong Buy, 1 Hold), indicating high conviction from bulls but also caution.

Weekly Outlook

Expect extreme volatility and potential consolidation after the parabolic move. The immediate range is between $115 (pivot) and $155 (resistance). A sustained break above $155 could target the $180-200 zone. A failure to hold $115 may lead to a retest of the $83 support.

Risk Disclaimer ⚠️

This is a high-risk, high-volatility biotech stock. The current price is driven by M&A speculation, not fundamentals or revenue. The extreme overbought RSI suggests a sharp correction is possible. Do your own research and invest only what you can afford to lose. This is not financial advice.

---

😍 Been eyeing Tiger merch but short on Tiger Coins? Now's your chance.

🎁 We’ve selected 4 high-demand items across practial, lifestyle, and learning, now with a lower redemption threshold!

Hot Merch Returns · Up to 43% Off